Langerhans cell histiocytosis.

Abstract excerpt

Langerhans cell histiocytosis (LCH) is caused by clonal expansion of myeloid precursors that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ involvement and dysfunction. The pathogenic cells are defined by constitutive activation of the MAPK signaling pathway. Treatment of LCH is risk-adapted: patients with single lesions may respond well to local treatment, whereas patients...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Histiocytosis, Langerhans-Cell
• Share to MAP Kinase Signaling System
• Share to Mutation